In 2018 the Drug Enforcement Administration audited a pharmacy on West Main Street in Meriden and discovered a shortage of more than 2,000 tablets of various controlled substances. The government alleged that the pharmacy failed to keep complete and accurate records of the receipt and dispensing of controlled substances and failed to maintain effective controls to guard against diversion.
The government further alleged that the pharmacy failed to report a theft or loss of controlled substances to the DEA within one business day of discovery, failed to maintain a complete and accurate biennial inventory, failed to properly complete DEA 222 order forms, dispensed seven controlled substance prescriptions under a different physician name or DEA registration number than written, and dispensed one prescription without the prescriber's DEA registration number.
Under a civil settlement announced in March 2021, the pharmacy and its owner agreed to pay penalties of $16,800 plus interest. The pharmacy also entered into a Memorandum of Agreement with the DEA requiring it to hire an independent third-party pharmacy consultant. The settlement resolved the allegations without a finding of liability.